HomeNewsIndiaNo Delta plus variant of COVID-19 found in 376 samples tested in Mumbai: BMC

No Delta plus variant of COVID-19 found in 376 samples tested in Mumbai: BMC

Additional municipal commissioner (western suburbs) Suresh Kakani said the samples were examined at a genome sequencing facility inaugurated in the city last month.

September 17, 2021 / 07:42 IST

No Delta plus variant of COVID-19, considered highly contagious, was found among 376 samples tested in the second round of genome sequencing in Mumbai, a senior civic official said.

Additional municipal commissioner (western suburbs) Suresh Kakani said the samples were examined at a genome sequencing facility inaugurated in the city last month.

In a statement issued by the BMC, Kakani said, “The genome sequencing facility at civic-run Kasturba Hospital has tested 376 samples so far (in second round). Not a single sample was found with the Delta plus variant of COVID-19.”

“However, 304 samples had the Delta variant, while two samples had 19A lineage and four 20A lineage. The other 66 samples have prevalence of earlier strain of COVID-19. The Delta plus variant, which is known for its higher transmissibility, was not found in these samples,” he said.

In the first batch of genome sequencing, 188 samples were tested of which 128 had the Delta variant, while the remaining had standard COVID-19 strain, the civic body said in the statement.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The analysis of the first report is out which revealed that out of 128 samples, 93 were from Mumbai. Out of these 93, 45 samples were of men and 48 were of women.

As many as 54 persons out of these 93 had to be hospitalized, which in terms of percentage comes at 58, the statement said.

The remaining people had no symptoms, it said.

Among the 93 persons, 47 had taken at least one dose of vaccines against COVID-19. A further break-up stated that 27 persons had taken both doses of the vaccine, while remaining got infected after receiving the first shot.

Only four persons had to be put on oxygen support out of the 27 fully vaccinated people , the statement said.

As many as 1,194 people who had come in contact with these 93 persons from Mumbai were tested for COVID-19. Of these, 80 people had contracted the infection, the civic body said.

PTI
first published: Sep 17, 2021 07:43 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347